Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000541130 | SCV000640030 | benign | Creatine transporter deficiency | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697309 | SCV000715893 | likely benign | not provided | 2020-07-16 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002314990 | SCV000848164 | likely benign | Inborn genetic diseases | 2023-09-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000541130 | SCV003823851 | uncertain significance | Creatine transporter deficiency | 2020-11-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004755956 | SCV005355197 | benign | SLC6A8-related disorder | 2024-09-04 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |